Mark DeStefano
Global Technology Innovation, Combination Products and Device Research & Development

About

Mark DeStefano is Director, Global Technology Innovation, Combination Products and Device Research & Development at Teva Pharmaceuticals. He obtained his Bachelor of Science in Mechanical Engineering from Drexel University (Philadelphia, PA, US) in 1985 and has been developing medical devices since 1990.

Contributions

PHARMA VIEW

ALTERNATIVE APPROACH FOR DEVICE SUBSTITUTABILITY: HUMAN FACTORS STUDIES FOR GENERICS & BIOSIMILARS

Carrie O’Donel, Henri Akouka, Mark DeStefano along with Leslie Sanchez-Torres, discuss the shortcomings of current comparative use approaches to determining substitutability of devices for generics and biosimilars and propose an alternative approach to human factors studies based on long-standing methodologies that has the potential to unlock innovation and improve the user experience for patients.